G2HIL6 (G2HIL6_PANTR) Pan troglodytes (Chimpanzee)
T-complex protein 1 subunit alpha UniProtKBInterProSTRINGInteractive Modelling
      556 aa; Sequence (Fasta) ;
      
      3 identical sequences: Homo sapiens:  P17987; Pan troglodytes:  A0A6D2VYN1; Gorilla gorilla gorilla:  G3RDV8
Available Structures
50 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| cryo-EM structure of human TRiC-ATP-closed state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | ||||
| Human TRiC-tubulin-S3 | 
                        Heteromer P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| cryo-EM structure of human TRiC-ADP-AlFx | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 10 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT-G beta 5 complex closed state 8 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 0 | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT-G beta 5 complex closed state 7 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 9 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 15 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 5 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| Human TRiC complex in closed state with nanobody Nb18, actin and PhLP2A bound | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P63261; P78371; Q99832; Q9H2J4;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT-G beta 5 complex closed state 6 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| Human TRiC complex in closed state with nanobody and tubulin bound | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13885; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex close state 11 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 13 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 12 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 14 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 1 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 3 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex best PhLP1 class | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT-G beta 5 complex closed state 4 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| CCT G beta 5 complex closed state 2 | 
                        Heteromer O14775; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| The beta-tubulin folding intermediate I | 
                        Heteromer P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 8×MG; 8×ADP; 8×AF3; | |||
| The beta-tubulin folding intermediate II | 
                        Heteromer P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 8×AF3; 8×MG; 8×ADP; | |||
| The beta-tubulin folding intermediate III | 
                        Heteromer P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 8×MG; 8×ADP; 8×AF3; | |||
| The beta-tubulin folding intermediate IV | 
                        Heteromer P07437; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 8×MG; 8×ADP; 8×AF3; | |||
| hTRiC-hPFD Class6 | 
                        Heteromer O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;  | 100 | ||||
| hTRiC-hPFD Class4 | 
                        Heteromer O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;  | 100 | ||||
| Human TRiC complex in closed state with nanobody bound (Consensus Map) | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| Human TRiC-PhLP2A-actin complex in the closed state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P60709; P78371; Q99832; Q9H2J4;  | 100 | ||||
| hTRiC-hPFD Class5 | 
                        Heteromer O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;  | 100 | ||||
| hTRiC-hPFD Class1 (No PFD) | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | ||||
| hTRiC-hPFD Class2 | 
                        Heteromer O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;  | 100 | ||||
| hTRiC-hPFD Class3 | 
                        Heteromer O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;  | 100 | ||||
| Human TRiC in ATP/AlFx closed state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | ||||
| Human TRiC/CCT complex with reovirus outer capsid protein sigma-3 | 
                        Heteromer P03527; P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 1×ZN; | |||
| Human TRiC-PhLP2A complex in the closed state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4;  | 100 | 16×ADP; 16×MG; 16×AF3; | |||
| Apo TRiC in closed conformation | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×MG; 16×ADP; 16×AF3; | |||
| Human TRiC open state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100.0 | 6×ADP; | |||
| Cryo-EM structure of human TRiC-tubulin-S2 | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ATP; | |||
| cryo-EM structure of human TRiC-ADP | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 16×ADP; | |||
| Cryo-EM structure of Human TRiC-ATP-open state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | ||||
| Cryo-EM structure of human TRiC-NPP state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | ||||
| Human TRiC-PhLP2A complex in the open state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4;  | 100 | 10×ADP; | |||
| Open state CCT-G beta 5 complex | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100.0 | 16×ADP; | |||
| CCT G beta 5 complex intermediate state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100.0 | 16×ADP; | |||
| Cryo-EM structure of human TRiC-tubulin-S1 state | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100 | 6×ADP; | |||
| Human CCT:mLST8 complex | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100.0 | 2×ADP; | |||
| Human TRiC complex in open state with nanobody bound | 
                        Heteromer P17987; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;  | 100.0 | 16×MG; 16×ADP; 12×AF3; | |||
| Prefoldin-tubulin-TRiC complex | 
                        Heteromer O15212; O60925; P17987; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;  | 100 | 4×ADP; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7nvm.1.A | monomer | 0.76 | 1×ADP; 1×AF3; | 100.00 | ||